These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7523522)

  • 1. Epitope specificity determines the ability of anti-Ro52 autoantibodies to precipitate Ro ribonucleoprotein particles.
    Peek R; Pruijn GJ; van Venrooij WJ
    J Immunol; 1994 Nov; 153(9):4321-9. PubMed ID: 7523522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accessibility of epitopes on the 52-kD Ro/SSA protein (Ro52) and on the RoRNP associated Ro52 protein as determined by anti-peptide antibodies.
    Ricchiuti V; Pruijn GJ; Thijssen JP; van Venrooij WJ; Muller S
    J Autoimmun; 1997 Apr; 10(2):181-91. PubMed ID: 9185880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy.
    Rutjes SA; Vree Egberts WT; Jongen P; Van Den Hoogen F; Pruijn GJ; Van Venrooij WJ
    Clin Exp Immunol; 1997 Jul; 109(1):32-40. PubMed ID: 9218821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the molecular composition of Ro ribonucleoprotein complexes. Identification of novel Y RNA-binding proteins.
    Fabini G; Rutjes SA; Zimmermann C; Pruijn GJ; Steiner G
    Eur J Biochem; 2000 May; 267(9):2778-89. PubMed ID: 10785401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of antigenically intact Ro ribonucleoproteins; biochemical and immunological evidence that the 52-kD protein is not a Ro protein.
    Boire G; Gendron M; Monast N; Bastin B; Ménard HA
    Clin Exp Immunol; 1995 Jun; 100(3):489-98. PubMed ID: 7774061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress-induced cell surface expression and antigenic alteration of the Ro/SSA autoantigen.
    Igarashi T; Itoh Y; Fukunaga Y; Yamamoto M
    Autoimmunity; 1995; 22(1):33-42. PubMed ID: 8882420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block.
    Eftekhari P; Sallé L; Lezoualc'h F; Mialet J; Gastineau M; Briand JP; Isenberg DA; Fournié GJ; Argibay J; Fischmeister R; Muller S; Hoebeke J
    Eur J Immunol; 2000 Oct; 30(10):2782-90. PubMed ID: 11069058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sera from patients with rheumatic diseases recognize different epitope regions on the 52-kD Ro/SS-A protein.
    Bozic B; Pruijn GJ; Rozman B; van Venrooij WJ
    Clin Exp Immunol; 1993 Nov; 94(2):227-35. PubMed ID: 7693382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody responses to the "native" 52-kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjogren's syndrome.
    Buyon JP; Slade SG; Reveille JD; Hamel JC; Chan EK
    J Immunol; 1994 Apr; 152(7):3675-84. PubMed ID: 7511655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human autoantibodies directed against the RNA recognition motif of La (SS-B) bind to a conformational epitope present on the intact La (SS-B)/Ro (SS-A) ribonucleoprotein particle.
    Rischmueller M; McNeilage LJ; McCluskey J; Gordon T
    Clin Exp Immunol; 1995 Jul; 101(1):39-44. PubMed ID: 7542577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies reactive with small ribonucleoprotein antigens: a convergence of molecular biology and clinical immunology.
    McNeilage LJ; Whittingham S; Mackay IR
    J Clin Lab Immunol; 1984 Sep; 15(1):1-17. PubMed ID: 6210367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis.
    Gkoutzourelas A; Liaskos C; Mytilinaiou MG; Simopoulou T; Katsiari C; Tsirogianni A; Daoussis D; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
    Front Immunol; 2018; 9():2835. PubMed ID: 30581434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block.
    Fritsch C; Hoebeke J; Dali H; Ricchiuti V; Isenberg DA; Meyer O; Muller S
    Arthritis Res Ther; 2006; 8(1):R4. PubMed ID: 16356190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ro ribonucleoprotein assembly in vitro. Identification of RNA-protein and protein-protein interactions.
    Slobbe RL; Pluk W; van Venrooij WJ; Pruijn GJ
    J Mol Biol; 1992 Sep; 227(2):361-6. PubMed ID: 1383550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human anti-Ro autoantibodies bind peptides accessible to the surface of the native Ro autoantigen.
    Huang SC; Yu H; Scofield RH; Harley JB
    Scand J Immunol; 1995 Mar; 41(3):220-8. PubMed ID: 7532872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjögren's syndrome.
    Ricchiuti V; Isenberg D; Muller S
    J Autoimmun; 1994 Oct; 7(5):611-21. PubMed ID: 7530962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune response to 52-kDa Ro and 60-kDa Ro is linked in experimental autoimmunity.
    Keech CL; Gordon TP; McCluskey J
    J Immunol; 1996 Oct; 157(8):3694-9. PubMed ID: 8871672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease.
    Peene I; Meheus L; De Keyser S; Humbel R; Veys EM; De Keyser F
    Ann Rheum Dis; 2002 Oct; 61(10):929-33. PubMed ID: 12228166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantigenic epitopes on hY5 Ro RNA are distinct from regions bound by the 60-kDa Ro and La proteins.
    Granger D; Tremblay A; Boulanger C; Chabot B; Ménard HA; Boire G
    J Immunol; 1996 Sep; 157(5):2193-200. PubMed ID: 8757346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera.
    Ricchiuti V; Briand JP; Meyer O; Isenberg DA; Pruijn G; Muller S
    Clin Exp Immunol; 1994 Mar; 95(3):397-407. PubMed ID: 7511075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.